• Publication Date: 10/01/2014
  • Author(s):
    Chamarthy, Sai Donovan, Brent Son, Yoen-Ju
  • Organization(s):
  • Article Type: Technical Articles
  • Subjects: Devices and Components, Product Development/Formulation
Pursuing inhaled therapies offers opportunities for changing route of administration, expanding indications, adopting fixed dose combinations and developing different formulation/device combinations.

Pulmonary delivery formulation and development require a commitment similar to that of a new product. Yet the clinical benefits and strong resistance of inhaled products to brand erosion can make pulmonary administration very attractive for product life management.

Download PDF